BioSpace News Archive

BROADWAY BELTS FOR PFF!, a benefit for the Pulmonary Fibrosis Foundation (PFF) raised a record $400,000 on Feb. 25 at Time Square’s Edison Ballroom

The Microbiome Therapeutics Innovation Group (MTIG) announced the publication of its Position Statement on Fecal Microbiota Transplantation (FMT) treatment.

According to a new study unveiled today by Susan G. Komen®, the world’s leading breast cancer organization, women across the country who have a suspicious finding from a screening mammogram are delaying, or even foregoing, needed diagnostic exams because of high out-of-pocket costs – with tragic potential consequences.

Approximately 40 percent of patients would benefit from having their cleft lip repair surgery in an ambulatory surgical center (ASC), instead of a traditional hospital setting, according to research published in the February 2019 issue of The Cleft Palate-Craniofacial Journal (CPCJ).

Bio-Path Holdings, Inc., a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, announced the closing of its previously announced offering.

A motion to dismiss was denied in a case that deals a blow to Illinois Department of Healthcare and Family Services in the agency’s attempt to set their own daily payment rates without consulting the Medicaid program.

Neovasc Inc. announced that it has successfully completed its 2019 mandatory Surveillance Audit with its Notified Body, resulting in the maintenance of the Regulatory Certification and maintenance of the ISO 13485: 2016 certification of the quality management system.

ViewRay, Inc. announced financial results for the fourth quarter and full year ended December 31, 2018.

BioLife Solutions, Inc. reported financial results and operational highlights for the fourth quarter and full year ended December 31, 2018.

Achieve Life Sciences, Inc. provided an update on the cytisinicline clinical development program and announced fourth quarter and year-end 2018 financial results.